The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2026 | Sleep disturbances following a hematological malignancy diagnosis: findings from a patient survey
Esther Oliva, MD, London North West University Healthcare NHS Trust, London, UK, discusses findings from a survey on the prevalence of sleep disturbances among patients with hematological malignancies, noting that almost 60% reported worsened sleep after diagnosis. Dr Oliva highlights that sleep problems are a significant aspect of patient wellbeing, often connected to anxiety, fatigue, and psychological distress, and emphasizes the importance of routine assessment of sleep in hematology care. This interview took place at the 31st Congress of the European Hematology Association (EHA) in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
